The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States

Colon Cancer

(2017) Paul F. Engstrom et al.   Journal of the National Comprehensive Cancer Network

The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients

(2015) Tomoya Tachi et al.   PLoS One

Risk of Incremental Toxicities and Associated Costs of New Anticancer Drugs: A Meta-Analysis

(2014) Saroj Niraula et al.   JOURNAL OF CLINICAL ONCOLOGY

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

(2014) Volker Heinemann et al.   LANCET ONCOLOGY

Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting

(2014) S. Hurvitz et al.   ONCOLOGIST

Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives

(2014) Florian Hohla   WORLD JOURNAL OF GASTROENTEROLOGY

Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative US Claims Database

(2013) Brian S. Seal et al.   BIODRUGS

Five-Year Mortality in Colorectal Cancer Patients with Ulcerative Colitis or Crohnʼs Disease

(2013) Anne G. Ording et al.   INFLAMMATORY BOWEL DISEASES

Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings

(2013) Derek Weycker et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

(2012) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study

(2012) J. C. Bendell et al.   ONCOLOGIST

Treatment of Febrile Neutropenia Is Expensive: Prevention Is the Answer

(2011) Jean A. Klastersky et al.   ONKOLOGIE

Costs of hospital events in patients with metastatic colorectal cancer

(2011) Jetty A. Overbeek et al.   JOURNAL OF MEDICAL ECONOMICS

Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies

(2011) Chakkarin Burudpakdee et al.   JOURNAL OF MEDICAL ECONOMICS

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE

Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice

(2010) Gregory P. Hess et al.   Journal of Oncology Practice

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE